| Код ТН ВЭД | 606061 |
Как аккредитованный завод Proto3000 Formlabs BioMed Amber, мы соблюдаем строгие протоколы качества - каждая партия подвергается строгим испытаниям для обеспечения последовательных стандартов эффективности и безопасности.
| Упаковка | |
| Доставка | |
| Хранение |
In maxillofacial and oral surgery, Proto3000-supplied Formlabs BioMed Amber resin is routed into guide workflows only after the surgical plan has been fixed in planning software and the guide has been assigned to a single-use protocol. The resin is dispensed directly from the cartridge without monomer dilution or addition of a secondary photoinitiator. The cartridge is equilibrated to 22°C for 30 min before the build starts because lower temperatures raise viscosity and reduce recoating uniformity on the platform. Prints are produced on a Formlabs Form 3B+ with a 405 nm laser, using the supplier-validated 50 µm layer thickness setting. The 50 µm setting is preferred when the guide contains sleeve holes of 2.0 mm diameter or when the intaglio surface must reproduce cortical bone landmarks with reduced stair-stepping artefact. Build orientation is arranged so that the tissue-facing surface is inclined 30° to 45° from the build plane. Support touchpoints are placed on non-tissue-bearing flanges and occlusal stops. After printing, the guide is transferred into a Form Wash containing 99% isopropyl alcohol. A 5-minute wash removes the uncured surface film. A second rinse in clean IPA is used if the first bath has exceeded its manufacturer-specified resin load. Compressed air not exceeding 0.2 MPa is applied through blind sleeve holes to clear solvent. The guide is air-dried for 30 min before post-cure. A Form Cure unit set to 60°C for 20 min completes polymerization. The post-cure window is not extended beyond the validated interval because the amber sections can develop thermal expansion stress if cooled from elevated temperature too quickly. The guide is inspected for dimensional drift. A 50 mm calibration bar printed in the same build is measured with a calibrated caliper. If the bar deviation exceeds the scanner tolerance used to define the CAD model, the batch is rejected. BioMed Amber is not suitable for autoclave sterilization. The heat deflection temperature under 0.45 MPa load is approximately 58°C. Steam autoclave exposure at 121°C exceeds this thermal endurance and produces warping. Low-temperature hydrogen peroxide gas plasma or cold sterilant soak is used instead, but each hospital cycle must be validated independently because cycle residuals can interact with the acrylic photopolymer network. The terminal device is a single-use pilot drill guide with a metal sleeve insertion. The cured resin meets the supplier’s stated ISO 10993-5 and ISO 10993-10 endpoints for limited mucosal contact. The ISO 10993-1 biological evaluation plan remains the responsibility of the medical device manufacturer. The printed guide is identified by resin lot, printer serial number, and post-cure date. The intaglio surface is not coated with a topical sealant unless the sealant is validated against ISO 10993-23 irritation endpoints. In this application the wash and post-cure log is part of the device master record, not an auxiliary process note.
Anatomical models printed from diagnostic CT data often enter hospital additive manufacturing labs as non-patient-contact tools for surgical planning and patient communication. In this use case, BioMed Amber is selected not primarily for biocompatibility statements but because the amber translucent matrix reveals internal neurovascular structures when hollow segmentation is used. The build file is generated from DICOM data with a slice thickness of 0.625 mm. The limiting dimensional error is therefore the voxel spacing, not the 100 µm layer height of the printer. The model is printed on a Formlabs Form 3B+ with 100 µm layers. No biological evaluation is required under ISO 10993-1 because the model does not contact the patient. The quality record is maintained under ISO 13485 document control if the model is used in a diagnostic workflow. Print orientation is chosen to reduce support tips on convex anatomy. After printing, the model is washed in 99% IPA for 5 min, air-dried, and post-cured at 60°C for 20 min. The largest model dimension in this category is typically 220 mm. Longer models are sectioned and bonded with a methacrylate adhesive, but adhesive joints are kept outside the region of interest because joint lines create visual artefacts under surgical loupes. A 50 mm calibration coupon printed in the same build is measured before the model is accepted for tumor board review. The terminal product is a translucent amber anatomical study model used by vascular, orthopedic, or oncology teams. The main process constraint is not post-cure shrinkage but storage humidity. BioMed Amber is hygroscopic enough that models stored at relative humidity above 60% for more than 72 h can show measurable mass gain. Moisture uptake alters dimensional stability of thin-walled models but does not itself produce cytotoxic leachables. Published data for the moisture absorption rate of this specific resin under hospital display conditions is limited, so each facility should maintain a local storage log rather than rely on supplier maximums. The internal layer structure from the 100 µm print setting is acceptable for visual planning but should not be used to size implant hardware without a second independent measurement. Critical dimensions for implant selection are taken from the original DICOM data, not from the printed model.
Endoscopic or airway device housings occasionally move from machined PEEK or ABS prototypes into additively manufactured pre-production parts when patient-specific angulation is required. BioMed Amber is considered for these housings because it has supplier-documented biological endpoints for short-term mucosal contact. The material is processed on a Form 3B+ with 100 µm layer thickness, but pilot production should not assume that the manufacturer’s standard wash and cure cycle is sufficient for complex internal channels. A housing with a 3.0 mm internal lumen and 2.0 mm wall thickness requires a different solvent path than a solid block. The first wash in 99% IPA is 5 min. The housing is then inverted and a syringe flushes clean IPA through the lumen at 50 mL per channel. The second wash is performed in a separate bath to avoid transferring dissolved monomer back onto the surface. Post-curing in a Form Cure at 60°C for 20 min is followed by a dry-air purge. The part is not autoclaved. The resin’s HDT of approximately 58°C at 0.45 MPa is below the 121°C steam autoclave condition. Low-temperature hydrogen peroxide gas plasma is used if the sterility assurance level must be 10⁻⁶, but the facility must verify that the plasma cycle does not cause surface cracking. The compliance package for this application includes ISO 10993-5, ISO 10993-10, and ISO 10993-23 for the cured resin. The device manufacturer is responsible for ISO 10993-12 extraction studies on the finished housing because the surface area-to-volume ratio changes after post-processing. Extraction is performed using both saline and sesame oil vehicles to mimic polar and non-polar body fluid interaction. The terminal component is a disposable camera or airway accessory housing that contacts mucous membranes for less than 24 h. The major process conflict is residual monomer in blind threaded inserts. Blind holes with an internal thread do not drain during washing, and uncured resin accumulates at the thread root. If the hole is printed with a closed bottom, it must be drilled through to create a drain path before washing. Alternatively, the thread is cut after curing with a biocompatible tap and the cavity is cleaned separately. No additional monomer is added to the resin. Using uncured resin from a previous print run to fill cracks is not permitted because the repair interface can produce different crosslink density and a local irritation risk. The printed housings are labeled with material lot and post-cure date. In a pilot production batch of 50 parts, the most common failure is not mechanical fracture but surface tack after abbreviated washing. Surface tack indicates residual unpolymerized monomer and must trigger a repeated wash and cure cycle, followed by re-evaluation against ISO 10993-5.
In orthodontic aligner production, BioMed Amber dental models are substituted for gypsum casts only after the vacuum-forming cycle has been characterized for peak sheet temperature and contact time. The resin is printed at 100 µm layer height on a Form 3B+ because the aligner shell does not require the finer 50 µm setting. The model is oriented with the occlusal plane inclined 25° to 35° from the build platform to reduce stair-stepping on the labial surfaces. Supports are placed on the model base only. After printing, the model is washed in 99% IPA for 5 min, dried, and post-cured at 60°C for 20 min. The model is not used for direct patient contact, so ISO 10993 testing is not applicable to the printed aligner tool. The terminal product is a vacuum-formed clear aligner model made from a 0.75 mm PET-G sheet. The PET-G sheet is heated to its forming temperature, typically 120°C, and is pressed onto the room-temperature BioMed Amber model. The brief contact does not normally raise the bulk model temperature above the resin’s HDT of 58°C. However, if the model is pre-heated in a drying oven or if the sheet dwell time exceeds 15 s, the amber model can soften at the cusp tips and smear. Smearing changes the aligner fit and is detected as a dull surface finish on the formed shell. This processing boundary is specific to BioMed Amber. Gypsum models withstand the same forming cycle without deformation at the cusp level. Published data for the exact surface temperature reached during vacuum forming on BioMed Amber models is limited, so dental labs typically verify the first five models in a batch with a thermocouple embedded in a sacrificial model at the first molar cusp. The model is stored in a low-dust environment after curing. IPA left on the surface before forming can cause local solvent whitening when the hot PET-G sheet contacts residual alcohol, so the models are air-dried for a minimum of 30 min after washing. The aligner model is scrapped after 10 forming cycles because repeated thermal contact accumulates surface microcracks at the cusp tips. The ISO 13485 quality record includes the printer serial number, resin lot, cure time, and forming cycle counter. This application uses the resin’s dimensional stability and stiffness, not its cytocompatibility. The compliance focus is therefore on the dental laboratory’s quality management system rather than on ISO 10993 biological evaluation. The resin cartridge is warmed to 22°C before printing to ensure consistent recoating. Low room temperature below 18°C increases viscosity and produces thin layer lines that weaken the cusp tips. The use of a Form Wash with a dirty solvent bath is the most common cause of rejected aligner models because uncured resin residues transfer onto the model base and contaminate the vacuum former.
In vitro diagnostic equipment manufacturers sometimes use BioMed Amber for fluid manifold prototypes that transport saline, reagents, or buffer solutions outside the patient. The material is selected because its amber transparency allows visual inspection of trapped air bubbles during pump priming. The part is printed at 100 µm layer height on a Form 3B+ or on a larger platform if the manifold exceeds the Form 3B+ envelope. The resin is not blended with a diluent. The cartridge is agitated gently before use to redisperse pigments that may settle during storage. The manifold is oriented so that each internal channel is as vertical as possible to allow resin drainage during printing and IPA flow during washing. A manifold with 1.5 mm internal channels is washed for 5 min in 99% IPA, then flushed with 50 mL clean IPA per channel. The same channel diameter is then air-purged with 0.2 MPa compressed air for 10 s per port. Post-cure is set to 60°C for 20 min in a Form Cure. The terminal component is a disposable reagent manifold with integrated Luer lock fittings. The biocompatibility requirement for this application is not automatically satisfied by the resin supplier’s USP Class VI statement. The finished manifold must be extracted according to USP Class VI protocols on the entire device, not only on the raw cured resin. A typical extraction matrix includes saline, an alcohol, and a lipophilic solvent, with extraction conditions selected from USP <88> based on intended use. The printed manifold is evaluated under ISO 10993-18 for leachables if the fluid path contacts the patient indirectly through an IV line. The most significant process conflict is residual uncured resin at the bottom of closed channels. A closed blind channel traps liquid resin during printing and solvent during washing. If the manifold cannot be redesigned with an open drain path, the prototype is printed in sections and solvent-bonded after curing. Solvent bonding with methacrylate cement at the joint can introduce a new chemical entity that must be included in the extraction study. The operational boundary is that BioMed Amber is not approved for long-term patient contact. The maximum use temperature after cure is controlled by the heat deflection temperature of approximately 58°C at 0.45 MPa. The manifold must not be steam sterilized or exposed to pressurized hot water above that threshold. Low-temperature hydrogen peroxide plasma is acceptable only after mechanical testing shows no stress cracking at the Luer fittings. The hardness of the cured resin is sufficient for threaded Luer connections but tightening torque must be limited to a starting value of 0.5 N·m until device-level validation is complete. Torque validation is not supplied by the resin manufacturer; it is a device-level test using a calibrated torque screwdriver. This application demonstrates that a biocompatible resin does not make the entire manifold automatically compliant. The ISO 10993-1 evaluation plan and the extraction study remain with the medical device manufacturer.
| Biological endpoint | Standard / method | Typical acceptance requirement |
|---|---|---|
| Cytotoxicity | ISO 10993-5 MEM elution | No greater than Grade 2 reactivity |
| Skin sensitization | ISO 10993-10 LLNA or GPMT | No sensitization response |
| Irritation | ISO 10993-23 intracutaneous reactivity | No erythema or oedema greater than control |
| Systemic toxicity | USP Class VI extraction | No systemic toxicity in specified animal test |
Custom in-ear monitor and hearing aid shells produced from digital ear impressions require a smooth acoustic bore to avoid acoustic reflections. BioMed Amber is used in this application because the cured resin can be printed at 50 µm layer height on a Form 3B+. The ear impression is scanned with a dedicated ear scanner. The shell is offset from the canal wall by 0.2 mm to 0.3 mm to leave room for a biocompatible coating. The print orientation is set so that the acoustic bore is vertical, with the canal tip facing the build platform. This reduces stair-stepping inside the bore. Supports are confined to the faceplate edge. After printing, the shell is washed in 99% IPA for 5 min in a Form Wash. A syringe pushes clean IPA through the acoustic bore to remove unpolymerized resin from the 1.8 mm diameter channel. The part is dried for 30 min and then post-cured at 60°C for 20 min. The terminal device is a shell that will be coated with a biocompatible lacquer before patient use. The uncoated BioMed Amber shell has supplier documentation for short-term skin contact, but the final in-ear device remains the responsibility of the hearing aid manufacturer or audiologist. The shell is not intended for long-term implantation. The amber color is used to visually inspect wall thickness with a dial gauge. A shell with a wall thickness below 1.2 mm is rejected because the lacquer coating may not fill microporosity and because the shell may crack during insertion. The main process conflict is bore shrinkage after post-cure. The acoustic bore diameter is printed oversized by 0.1 mm to compensate for post-cure volumetric change. This compensation factor is validated per batch because the degree of shrinkage varies with shell volume and resin lot. A calibration pin gauge of 1.8 mm diameter is passed through the bore after curing. If the pin gauge binds, the shell is rejected or the bore is reamed by hand with a slow spiral bur. The use of a low-speed rotary tool above 10,000 rpm generates frictional heat that can melt the resin at the bore edge, so hand reaming is preferred. Ethylene oxide sterilization of the uncoated shell may be used, but it must be followed by aeration to allow residual gas to dissipate. Autoclaving is not used because the 121°C environment exceeds the material’s heat deflection temperature of approximately 58°C. The compliance record for each shell includes the resin lot, printer serial number, post-cure log, and pin gauge check. The shell is then ready for coating and receiver installation. This application produces a component whose final biocompatibility depends on both the resin and the coating system. The coating supplier’s ISO 10993-5 and ISO 10993-10 data must be reviewed before the shell enters clinical use. The processing window is narrow because the acoustic bore and the canal fit cannot both be adjusted independently after the shell is printed.
Конкурентные цены на Proto3000 Formlabs BioMed Amber, которые соответствуют вашему бюджету - гибкие условия и индивидуальные котировки для каждого заказа.
Для получения образцов, цен или более подробной информации свяжитесь с нами по адресу +8618136850665 или отправить по почте admin@ascent-chem.com.
Мы ответим вам как можно скорее.
Телефон: +8618136850665
Электронная почта: admin@ascent-chem.com
Гибкие условия оплаты, конкурентоспособные цены, первоклассное обслуживание — обращайтесь прямо сейчас!
Proto3000 distributes Formlabs BioMed Amber Resin as a 1 L cartridge-formulated stereolithography photopolymer intended for use on Form 3B, Form 3BL, and Form 3B+ hardware platforms. The cured polymer is a rigid, amber-translucent solid with manufacturer-published typical values of 48 MPa tensile strength at break per ASTM D638-14, 1.8 GPa flexural modulus per ASTM D790-17, and 82 Shore D hardness per ASTM D2240-15. Biocompatibility assessment follows ISO 10993-1:2018 for limited-duration skin and mucosal membrane contact, supported by in vitro cytotoxicity data under ISO 10993-5:2009, irritation testing under ISO 10993-23:2021, and skin sensitization testing under ISO 10993-10:2010. Cartridges are manufactured within an ISO 13485:2016 quality management system. The material is not classified for permanent implantation or for prolonged mucosal contact exceeding 24 h without device-specific revalidation.
Manufacturer-validated workflows for BioMed Amber Resin specify print layers of 100 µm and 50 µm on Form 3B/3B+ platforms. The printer’s closed-loop resin temperature control maintains viscosity within the recoat window; cartridges must be agitated before insertion because the amber pigment settles during storage. Uncured resin contains methacrylated monomers and is classified as a skin and eye irritant. Handling therefore requires nitrile gloves, eye protection, and local exhaust ventilation during solvent washing. After printing, parts are washed in 99% isopropyl alcohol in a Form Wash or equivalent dual-bath system to reduce residual uncured monomer. The post-cure step uses a Form Cure unit at 60 °C for 20 min. Incomplete post-cure raises residual monomer content and can move cytotoxicity results outside the acceptance range of ISO 10993-5:2009. Field observations on production lines show that insufficient solvent exchange leaves a tacky surface and produces a low Shore D reading even after full post-cure. Worn resin tank PDMS layers can also generate low-fill parts because optical transmission decreases; amber-pigmented resins often reduce tank service life relative to clear formulations.
Print speed, laser power, and layer height are locked by the printer firmware when a BioMed Amber Resin cartridge is inserted. The cartridge RFID communicates material type, volume remaining, and expiration; printing with an expired cartridge is blocked. This lockout reduces the risk of using settled or partially gelled resin but requires inventory rotation because cartridges carry a finite shelf life. Proto3000’s compatibility matrix should be checked before use on Form 4B or any hardware revision not listed on the cartridge label.
Mechanical anisotropy is significant in SLA-fabricated parts. Tensile specimens printed in the XY plane and then post-cured exhibit higher tensile strength than those printed vertically because interlayer adhesion is not fully equivalent to intra-layer crosslink density. For BioMed Amber Resin, orienting parts at shallow angles from the build platform improves load transfer along tensile axes but increases support contact area and finishing time. When dimensional accuracy is critical, flat orientation reduces Z-axis stepping but may expose the part to increased suction force, which can detach fine supports on worn build platforms.
Table 1 lists manufacturer-published typical mechanical values for fully post-cured BioMed Amber Resin. These values are not batch-release specifications and should be treated as material selection data rather than design allowables. Specimens are conditioned at 23 °C and 50% RH for 24 h before testing.
| Property | Test method | Reported typical value |
|---|---|---|
| Tensile strength at break | ASTM D638-14 | 48 MPa |
| Tensile modulus | ASTM D638-14 | 1.7 GPa |
| Elongation at break | ASTM D638-14 | 9% |
| Flexural strength | ASTM D790-17 | 70 MPa |
| Flexural modulus | ASTM D790-17 | 1.8 GPa |
| Notched Izod impact | ASTM D256-10 | 24 J/m |
| Heat deflection temperature at 0.45 MPa | ASTM D648-18 | 58 °C |
| Shore D hardness | ASTM D2240-15 | 82 |
The combination of high tensile modulus and low notched Izod impact energy places BioMed Amber in the rigid glassy photopolymer category. Thin-wall sections below 1.0 mm may fail in a brittle mode under snap-fit or impact loading. The heat deflection temperature of 58 °C at 0.45 MPa is below steam autoclave temperature, so parts must be supported or unloaded during steam sterilization to avoid creep deformation.
Manufacturer documentation lists steam autoclave at 121 °C for 30 min and gamma irradiation at 25 kGy as validated sterilization endpoints for BioMed Amber Resin. Dimensional drift after steam exposure is anisotropic; the largest deviation typically occurs along the build Z-axis because layer-wise residual stress relaxes above the heat deflection temperature. Ethylene oxide processing must be qualified at the device level under ISO 11135:2014, because residual ethylene oxide retention depends on wall thickness, infill pattern, and aeration time. Terminal sterilization should be followed by re-assessment of cytotoxicity under ISO 10993-5:2009 on the finished device, not solely on raw coupons, when packaging or load density changes.
Regulatory documentation for Proto3000-supplied BioMed Amber Resin cartridges centers on the biocompatibility matrix in Table 2. The resin is not a standalone medical device; it is a raw material input to a device-specific risk file under ISO 14971:2019. Final device biocompatibility therefore depends on post-processing, sterilization, and patient-contacting geometry.
| Standard designation | Scope | Reported relevance |
|---|---|---|
| ISO 10993-5:2009 | In vitro cytotoxicity | Pass |
| ISO 10993-10:2010 | Skin sensitization | Pass |
| ISO 10993-23:2021 | Irritation | Pass |
| ISO 13485:2016 | Quality management for medical device manufacturing | Certified cartridge production |
| ISO 14971:2019 | Risk management | User-supported device risk file |
Because the resin is not supplied sterile, the final device manufacturer retains responsibility for validating the sterilization method and maintaining technical files under applicable medical device regulations. Proto3000 supplies batch traceability documents; cartridge lot numbers should be linked to finished device lots. Raw material traceability under ISO 13485:2016 is a prerequisite for limited-contact devices; loss of batch linkage invalidates the biocompatibility file and requires revalidation. For applications requiring short-term mucosal contact, the cured surface finish should be polished to reduce surface roughness. Published data for this specific configuration is limited when surface roughness is high; the manufacturer does not supply a universal Ra threshold. Therefore, device-specific validation under ISO 10993-1:2018 remains necessary. The material is not suitable for permanent implantation, for contact with breached skin, or for repeated autoclave exposure beyond the number of cycles qualified in the device validation.
Compared with BioMed Clear Resin, BioMed Amber Resin differs mainly in spectral transmittance and color coordinates. BioMed Clear is formulated for maximum visible light transmission, while BioMed Amber contains a yellow-amber pigment that reduces short-wavelength transmittance and improves contrast against tissue and stainless steel. Published mechanical values for the two stiff BioMed materials are closely aligned; selection is therefore driven by optical inspection needs rather than by a substantial change in stiffness. BioMed Black Resin offers maximum contrast but is opaque and cannot be used for transmitted-light inspection. BioMed White Resin is used for anatomical models where high contrast against bone is needed but internal channel verification is not required. BioMed Elastic 50A Resin and BioMed Flex 80A Resin are elastomeric and are not interchangeable with rigid BioMed Amber in load-bearing applications.
The amber pigment provides selective absorption in the blue and violet region. This reduces glare under surgical lighting and improves contrast for camera-based inspection. Transmitted-light inspection of internal channels is possible in thin wall sections; thicker sections become translucent rather than fully transparent because the pigment scatters light. Published spectral transmittance curves are not a substitute for device-level optical verification because layer thickness and post-cure alter scattering.
BioMed Amber Resin is used for short-term intraoral appliances, surgical planning models, and rigid medical device components that require amber translucency and documented biocompatibility endpoints. For intraoral use, the cured surface should be polished because surface roughness influences biofilm retention; no universal Ra threshold is supplied by the manufacturer, so each device geometry must be evaluated under ISO 10993-23:2021 after the intended cleaning and sterilization protocol. The material is not intended for long-term mucosal contact, permanent implantation, or applications involving repeated exposure to strong oxidizing disinfectants without device-specific validation. Published data for this specific configuration is limited for cyclic autoclave loading in the presence of organic soil; cleaning validation should therefore include protein and endotoxin recovery.
Cured BioMed Amber parts can be machined, sanded, and polished using standard acrylic finishing tools. Wet sanding with fine abrasives reduces surface haze. Polishing compounds should be tested because some solvent-based compounds can plasticize the surface and alter hardness. Surface roughness after finishing should be measured according to ISO 4287:1997 when the device is intended for mucosal contact, because rough surfaces may retain biofilm after cleaning.
Batch-to-batch variance in amber pigment dispersion can shift the cured Shore D hardness if cartridges are not homogenized before printing. Failed lots typically present as sediment in the cartridge or as visible striation in cured parts parallel to the build axis. Re-pouring used resin from the tank back into the cartridge is not recommended because it alters pigment particle size distribution and can introduce micro-voids after post-cure. Unused resin should be stored at 10–25 °C in the dark; exposure to ambient light and moisture initiates premature polymerization and can elevate viscosity beyond the printer’s recoat window. Do not mix BioMed Amber Resin with other photopolymers or with solvent blends containing acetone or amines; such additions alter crosslink density and invalidate the ISO 10993-5:2009 assessment.